Creon 60000 [USP'U]/1 (Pancrelipase CAPSULE, DELAYED RELEASE PELLETS) 60000 [USP'U]/1

Creon 60000 [USP'U]/1 is a delayed-release pancreatic enzyme supplement designed to aid digestion. It contains pancrelipase, which helps break down fats, proteins, and carbohydrates. This medication is commonly used for individuals with exocrine pancreatic insufficiency.

Strength

60000 [USP'U]/1

Pack Size

250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-1212-07)

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Creon 60000 [USP'U]/1 is primarily used to manage digestive issues in individuals who have difficulty producing enough natural enzymes. It is often prescribed for conditions like chronic pancreatitis or cystic fibrosis. The pancrelipase in Creon helps the body digest fats, proteins, and carbohydrates more effectively, improving nutrient absorption and overall digestion.

Side Effects

Common effects of Creon 60000 [USP'U]/1 may include improved digestion and reduced symptoms of malabsorption. Some users might experience mild gastrointestinal discomfort, such as bloating or diarrhea, especially when starting the medication. These effects are generally temporary and may subside as the body adjusts to the enzyme supplement.

Precautions & Warnings

Creon 60000 [USP'U]/1 should be taken as directed by a healthcare provider. It is important to swallow the capsules whole and not crush or chew them to ensure the delayed-release mechanism works properly. Patients with known allergies to pork proteins should avoid this medication. Always consult a healthcare professional before starting any new medication.

Avoid Interactions

Creon 60000 [USP'U]/1 may interact with certain medications, particularly those that affect stomach acid production. It is advisable to avoid taking antacids within two hours of taking Creon, as they can interfere with its effectiveness. Additionally, always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Creon 60000 [USP'U]/1 is used to aid digestion in individuals with exocrine pancreatic insufficiency, helping to break down fats, proteins, and carbohydrates.

Creon 60000 [USP'U]/1 should be taken orally with meals or snacks, swallowed whole, and not crushed or chewed.

Common side effects may include mild gastrointestinal discomfort, such as bloating or diarrhea, which are usually temporary.

It is important to consult a healthcare provider before taking Creon 60000 [USP'U]/1 with other medications, as interactions may occur.

Creon 60000 [USP'U]/1 is not suitable for individuals with allergies to pork proteins. Always consult a healthcare professional before starting this medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.